Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in March

Group 1 - Pacira BioSciences, Inc. is committed to delivering innovative, non-opioid pain therapies to transform patients' lives [1][2] - The company has three commercial-stage non-opioid treatments: EXPAREL®, ZILRETTA®, and ioveraº® [2] - Pacira is advancing the development of PCRX-201, a novel locally administered gene therapy for treating prevalent diseases like osteoarthritis [2] Group 2 - Pacira will participate in the Raymond James 46th Annual Institutional Investors Conference on March 5th at 10:25 AM ET [3] - The company will also attend the Barclays 27th Annual Global Healthcare Conference on March 12th at 8:00 AM ET [3]